Market Cap 250.58M
Revenue (ttm) 0.00
Net Income (ttm) -51.04M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 793,400
Avg Vol 1,601,180
Day's Range N/A - N/A
Shares Out 32.59M
Stochastic %K 19%
Beta 3.60
Analysts Strong Sell
Price Target $29.17

Company Profile

Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops novel therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional metabolic and fibrotic pathways in the United States. The company's lead drug candidate is Denifanstat, an oral, once-daily pill and selective FASN inhibitor for the treatment of metabolic dysfunction-associated steatohepatitis, acne, and select forms of cancer. It also develops TVB-3567, a FASN...

Industry: Biotechnology
Sector: Healthcare
Phone: 650 561 8600
Address:
155 Bovet Road, Suite 303, San Mateo, United States
BioRich
BioRich May. 13 at 3:22 PM
$SLS Again, the $SLS and $ALT Nations can hate their Mayor, but he's really good at what he does. Took 40% gain in $SGMT (which I was very strong in and still dig) and rolled it into $HUMA (+33.75%) $GUTS (+32.66%), LGND (-8.66%) and VVOS (-13.22%), while SGMT went down ~3%. This is how it's done folks. For those that didn't sell at $6.60 last evening, you're already down 12.3% because you got greedy instead. Follow/Subscribe for more suggestions and perspective. Would love to hear yours too. That's how we find these gems and learn. Let's make some (more) money. Cheers! (Can only tag 5 tickers so will add cash tags to LGND and VVOS in comments, not omitting).
2 · Reply
dick_dasterdly
dick_dasterdly May. 13 at 3:57 AM
$SGMT Fortifying the position here and now it sits in Mr. Roth. No need to monitor here anymore. Quarterly check ins. That's it. I know where this is headed.
0 · Reply
buymoremakemore
buymoremakemore May. 13 at 2:25 AM
$SGMT They didn't mention the MASH combo phase 2 trial in their PR for Q1 ER. I know they mentioned it after the 175M capital raise. Just wonder why they didn't mention it at all. It's probably nothing and they just wanted to emphasize the pivot to acne.
2 · Reply
rational1
rational1 May. 12 at 4:02 PM
$SGMT Denifanstat as a mosquito repellant? Dries up Sebum oil in skin as KOL mentioned in recent presentation. NYT article today addresses. https://phys.org/news/2026-05-people-mosquito-magnets-clues-emerging.html
1 · Reply
rational1
rational1 May. 12 at 1:29 PM
$SGMT 4 cent earnings beat , not that it's an earnings story (yet)!
0 · Reply
Whiskeyunderthebed
Whiskeyunderthebed May. 12 at 1:13 PM
$SGMT we are getting some small bites recently
0 · Reply
focafoca99
focafoca99 May. 12 at 11:49 AM
$SGMT released its Q1 2026 financial results in a press release attached to its 8‑K filing.
0 · Reply
permabull869
permabull869 May. 9 at 12:11 AM
$SGMT when buyout 🥺
2 · Reply
buymoremakemore
buymoremakemore May. 8 at 5:09 PM
$SGMT Bought back half my original positon. 25k shares. Holding indefinitely for BO or when MC seems to have peaked after the acne drug worth billions.
1 · Reply
AngelInvestor_INF
AngelInvestor_INF May. 8 at 12:23 AM
$IFRX $SGMT This was a successful offer.
0 · Reply
Latest News on SGMT
Sagimet Biosciences reports Q1 EPS (33c), consensus (35c)

2026-05-12T11:45:46.000Z - 1 day ago

Sagimet Biosciences reports Q1 EPS (33c), consensus (35c)


Sagimet Biosciences Transcript: Status update

Apr 30, 2026, 2:00 PM EDT - 12 days ago

Sagimet Biosciences Transcript: Status update


3 Penny Stocks to Watch Now, 4/28/26

2026-04-28T18:07:00.000Z - 14 days ago

3 Penny Stocks to Watch Now, 4/28/26

HTCO YAAS


Sagimet Biosciences holds a conference call

2026-04-28T17:15:16.000Z - 14 days ago

Sagimet Biosciences holds a conference call


TD Cowen establishes $21 price target for Sagamet Bioscinces

2026-04-28T12:19:03.000Z - 15 days ago

TD Cowen establishes $21 price target for Sagamet Bioscinces


Sagimet Biosciences Provides Strategic and Corporate Updates

Apr 27, 2026, 7:00 AM EDT - 16 days ago

Sagimet Biosciences Provides Strategic and Corporate Updates


Sagimet Biosciences initiated with a Buy at Rodman & Renshaw

2026-03-26T11:46:26.000Z - 6 weeks ago

Sagimet Biosciences initiated with a Buy at Rodman & Renshaw


Sagimet Biosciences reports Q4 EPS (29c), consensus (43c)

2026-03-11T11:37:39.000Z - 2 months ago

Sagimet Biosciences reports Q4 EPS (29c), consensus (43c)


Sagimet Biosciences initiated with a Buy at Guggenheim

2026-02-03T12:21:07.000Z - 3 months ago

Sagimet Biosciences initiated with a Buy at Guggenheim


Sagimet Biosciences initiated with an Equal Weight at Barclays

2026-01-27T21:30:19.000Z - 3 months ago

Sagimet Biosciences initiated with an Equal Weight at Barclays


Sagimet Biosciences Transcript: KOL Event

Jun 16, 2025, 2:00 PM EDT - 11 months ago

Sagimet Biosciences Transcript: KOL Event


Sagimet Biosciences Transcript: KOL Event

May 29, 2025, 1:00 PM EDT - 1 year ago

Sagimet Biosciences Transcript: KOL Event


Sagimet Biosciences Transcript: Study Update

Jun 13, 2024, 12:30 PM EDT - 2 years ago

Sagimet Biosciences Transcript: Study Update


Sagimet Biosciences Transcript: Investor & Analyst Day 2024

May 23, 2024, 1:00 PM EDT - 2 years ago

Sagimet Biosciences Transcript: Investor & Analyst Day 2024


BioRich
BioRich May. 13 at 3:22 PM
$SLS Again, the $SLS and $ALT Nations can hate their Mayor, but he's really good at what he does. Took 40% gain in $SGMT (which I was very strong in and still dig) and rolled it into $HUMA (+33.75%) $GUTS (+32.66%), LGND (-8.66%) and VVOS (-13.22%), while SGMT went down ~3%. This is how it's done folks. For those that didn't sell at $6.60 last evening, you're already down 12.3% because you got greedy instead. Follow/Subscribe for more suggestions and perspective. Would love to hear yours too. That's how we find these gems and learn. Let's make some (more) money. Cheers! (Can only tag 5 tickers so will add cash tags to LGND and VVOS in comments, not omitting).
2 · Reply
dick_dasterdly
dick_dasterdly May. 13 at 3:57 AM
$SGMT Fortifying the position here and now it sits in Mr. Roth. No need to monitor here anymore. Quarterly check ins. That's it. I know where this is headed.
0 · Reply
buymoremakemore
buymoremakemore May. 13 at 2:25 AM
$SGMT They didn't mention the MASH combo phase 2 trial in their PR for Q1 ER. I know they mentioned it after the 175M capital raise. Just wonder why they didn't mention it at all. It's probably nothing and they just wanted to emphasize the pivot to acne.
2 · Reply
rational1
rational1 May. 12 at 4:02 PM
$SGMT Denifanstat as a mosquito repellant? Dries up Sebum oil in skin as KOL mentioned in recent presentation. NYT article today addresses. https://phys.org/news/2026-05-people-mosquito-magnets-clues-emerging.html
1 · Reply
rational1
rational1 May. 12 at 1:29 PM
$SGMT 4 cent earnings beat , not that it's an earnings story (yet)!
0 · Reply
Whiskeyunderthebed
Whiskeyunderthebed May. 12 at 1:13 PM
$SGMT we are getting some small bites recently
0 · Reply
focafoca99
focafoca99 May. 12 at 11:49 AM
$SGMT released its Q1 2026 financial results in a press release attached to its 8‑K filing.
0 · Reply
permabull869
permabull869 May. 9 at 12:11 AM
$SGMT when buyout 🥺
2 · Reply
buymoremakemore
buymoremakemore May. 8 at 5:09 PM
$SGMT Bought back half my original positon. 25k shares. Holding indefinitely for BO or when MC seems to have peaked after the acne drug worth billions.
1 · Reply
AngelInvestor_INF
AngelInvestor_INF May. 8 at 12:23 AM
$IFRX $SGMT This was a successful offer.
0 · Reply
SecretTradingTips
SecretTradingTips May. 7 at 9:08 PM
$SGMT Expectations for the earnings tomorrow?
0 · Reply
Ultrasound
Ultrasound May. 7 at 8:26 PM
$ALT $SGMT Lot's of $$$$ riding on these two Italian wise guys: Durso and D'Urso. They may have to add some additional muscle to negotiations like froggy legs or cement boots. Come on fellas - you guys are selling the real deal - no fugazi's here.
2 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser May. 7 at 7:11 PM
$SGMT RSI: 59.05, MACD: 0.6875 Vol: 1.17, MA20: 6.91, MA50: 5.91 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
rational1
rational1 May. 7 at 3:15 PM
$SGMT gave back all of yesterday's gain on 1/10th of the volume and no news nor commentary. But no manipulation here. Just move along. Nothing to see here. Geez
0 · Reply
Whiskeyunderthebed
Whiskeyunderthebed May. 5 at 4:06 PM
$SGMT repeat of yesterday-stealing shares again.
1 · Reply
perpetbill
perpetbill May. 5 at 2:49 PM
$SGMT when could the Chinese authorities rule on acne?
1 · Reply
Whiskeyunderthebed
Whiskeyunderthebed May. 5 at 12:52 PM
1 · Reply
Whiskeyunderthebed
Whiskeyunderthebed May. 4 at 8:06 PM
$SGMT In fact they were stealing shares today...
0 · Reply
Whiskeyunderthebed
Whiskeyunderthebed May. 4 at 5:58 PM
$SGMT this is getting fudged today-when bios are ripping.
0 · Reply
anachartanalyst
anachartanalyst May. 4 at 4:02 PM
$SGMT https://anachart.com/wp-content/uploads/2026/05/1777910512_soc-img.jpg
0 · Reply
rational1
rational1 May. 4 at 3:30 PM
$SGMT Canaccord raise price target to $49.
1 · Reply
SuperGreenToday
SuperGreenToday May. 4 at 11:35 AM
$SGMT Share Price: $7.61 Contract Selected: Oct 16, 2026 $10 Calls Buy Zone: $1.34 – $1.65 Target Zone: $2.36 – $2.88 Potential Upside: 66% ROI Time to Expiration: 164 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply